NORTH CANTON -- For the third quarter, Diebold reported net income of $35.8 million, or diluted earnings per share of 50 cents, excluding after-tax charges of $20 million related to the company's investment in InnoVentry, and $1.6 million for realignment, special charges and the operating loss of the recently divested MedSelect division.
Including the special charges, Diebold had net income of $14.2 million, or diluted 20 cents per share, on revenue of $444.6 million.
According to a Diebold news release, this compares to third quarter 2000 net income of $34.9 million, or diluted 49 cents per share on revenue of $479.9 million, which included non-recurring voting machine and MedSelect revenue of $53.6 million.
The company reported financial self-service revenue increases of 10 percent in Asia Pacific and 32 percent in Europe/Middle East/Africa and a financial self-service revenue decrease of 14 percent in the Americas.
